Schering extends use of Gadovist
The European Union has approved the use of Schering's extracellular agent Gadovist 1.0 for use in MR angiography. Gadovist 1.0 previously had been cleared for contrast-enhanced MR of the brain and spine by EU members and other countries, including the
The European Union has approved the use of Schering's extracellular agent Gadovist 1.0 for use in MR angiography. Gadovist 1.0 previously had been cleared for contrast-enhanced MR of the brain and spine by EU members and other countries, including the U.S. It is the first extracellular contrast agent to receive EU approval for this indication.